Datascope brings Anestar production to US:
This article was originally published in Clinica
Datascope is shifting production of its Anestar and Anestar S anaesthesia delivery systems from Germany to its facility in New Jersey, having bought the manufacturing rights to the devices from its OEM partner. The move will enable the company to enhance its line of anaesthesia systems without the restrictions of an OEM agreement as well as giving it a competitive boost in the anaesthesia delivery and OR (operating room) patient monitor markets. Datascope, of Montvale, New Jersey, estimates that these two markets together generate $700m in annual worldwide sales.
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.